Patent · US Active

Replication-competent VSV-HIV Env vaccines

US9925258B2 · kind B2 · utility

0Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 29, 2016
Grant dateMar 27, 2018
Priority date
Expiry dateSep 29, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2810/6081
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines for infectious diseases of AIDS. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.